Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial import inner membrane translocase subunit Tim23 (TIMM23) is an essential, integral membrane protein and core component of the TIM23 complex within the mitochondrial inner membrane[1][2][3]. The TIM23 complex mediates the translocation of proteins bearing an N-terminal presequence across the inner mitochondrial membrane into the mitochondrial matrix or their insertion into the inner membrane. TIMM23 forms part of the protein-conducting channel and interacts with several partners (including Tim17, Tim50, Tim21) to facilitate dynamic and regulated protein import. This import process is critical for mitochondrial biogenesis, respiratory chain assembly, and energy production. Dysregulation or overexpression of TIMM23 has been implicated in diseases such as non-small cell lung cancer, in which it promotes cell proliferation and survival, making it a candidate prognostic marker and therapeutic target[2]. No approved small-molecule drugs directly target TIMM23, though genetic inhibition in preclinical models impairs tumor growth and induces apoptosis[2]. Potential safety concerns relate to the protein’s central role in normal mitochondrial function in all cell types.
For RNAi/shRNA or CRISPR interventions: Inhibition of TIMM23 impairs mitochondrial protein import, disrupts mitochondrial function, lowers ATP production, and induces oxidative stress and apoptosis in target cells (e.g., cancer cells)[2]. No direct small-molecule or clinical inhibitor mechanism-of-action reported.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial import inner membrane translocase subunit Tim23 (TIMM23).